Welcome to our dedicated page for UNITED STATES ANTIMONY SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNITED STATES ANTIMONY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNITED STATES ANTIMONY's regulatory disclosures and financial reporting.
United States Antimony Corporation entered into an Amended and Restated Sales Agreement with A.G.P./Alliance Global Partners and B. Riley Securities to sell common stock through an at-the-market offering program. The agreement adds B. Riley as a sales agent and updates related terms.
The company filed a prospectus supplement to allow issuance of up to $65,000,000 of common shares under this program using its existing shelf registration. The company will set limits on timing, size, and minimum prices for sales, may suspend sales at its discretion, and will pay the sales agents up to 3.0% of gross proceeds as commission.
United States Antimony Corp (UAMY) prospectus supplement highlights that the company remains in the exploration stage and lists a broad set of operational, regulatory, market, geopolitical and financing risks that could materially affect its business. The disclosure notes concentration risks, fluctuations in antimony and precious metal prices, potential environmental and security issues in Mexico, and cybersecurity and supply-chain concerns. The company also discloses potential stock dilution from outstanding equity awards and several warrant series exercisable at specified prices, and reserves shares under its Equity Incentive Plan.
United States Antimony Corp (UAMY) insider filing: Richard R. Isaak, SVP and Chief Financial Officer, reported awards on May 27, 2025 that were filed on Form 4. He received a time-based restricted stock unit award covering 180,000 common shares that vests one-third each on May 27 of 2025, 2026 and 2027, subject to continued service and shareholder approval of the company’s Amended Restated 2023 Equity Incentive Plan. He also received a stock option covering 200,000 underlying shares with an exercise price of $2.57, vesting upon satisfaction of specified performance measures during the option’s 10-year term and also conditioned on shareholder approval.
John C. Gustavsen, President of the Antimony Division at United States Antimony Corp (UAMY), was granted equity awards on 05/27/2025 consisting of 125,000 restricted stock units (RSUs) and 150,000 stock options. Both grants are contingent on shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.
The RSUs vest time-based in three equal installments (one-third or 41,667 shares on each of May 27, 2025, 2026 and 2027) subject to continued service and shareholder approval. The stock options vest upon achievement of specified performance measures at any time during the options' 10-year term, subject to continued service and shareholder approval. Following the reported transactions, the filings indicate 0 shares beneficially owned from these awards until vesting/approval conditions are met.
Melissa M. Pagen, SVP of Corporate Development & Government Relations at United States Antimony Corp (UAMY), reported awards granted on 05/27/2025 that are contingent on shareholder approval of the companys Amended Restated 2023 Equity Incentive Plan. The filing shows a time-based RSU award for 100,000 shares vesting one-third on each of May 27, 2026, 2027 and 2028 subject to continued service and plan approval. It also shows a stock option for 150,000 shares with a $2.57 exercise price that vests upon meeting specified performance measures during its 10-year term, also contingent on shareholder approval. The Form 4 is signed 09/15/2025.
United States Antimony Corporation is registering an additional 15,000,000 shares of common stock under its Amended and Restated 2023 Equity Incentive Plan. This S-8 filing supports issuing stock-based awards such as options and restricted stock to employees, directors and other service providers.
The Amended and Restated 2023 Plan was approved by shareholders at the 2025 annual meeting on July 31, 2025, and increased the plan’s total share reserve to approximately 23,700,000 shares. As of September 4, 2025, 9,136,201 shares of common stock were subject to outstanding awards and 12,174,767 shares remained available for future grants under the plan.
The prospectus supplement for United States Antimony Corporation (UAMY) discloses that proceeds to the company after expenses and a credit will be $17,605,000. The document notes it was filed with the SEC on April 18, 2025, and describes that offered debt securities may be sold at a fixed price or prices, at prevailing market prices, at prices related to prevailing market prices, or at negotiated prices. No additional financial metrics, use of proceeds details, maturity, interest rates, or underwriting terms are provided in the excerpt.
United States Antimony Corporation appointed General (Ret.) John M. “Jack” Keane to its Board of Directors, effective August 13, 2025. He is a prominent foreign policy and national security authority who advises presidents, cabinet officials, members of congress, international leaders, and business leaders, and serves as Chairman of the Institute for the Study of War and as a member of the Secretary of Defense Policy Board.
General Keane will serve as a director until the next annual meeting of shareholders and until a successor is elected and qualified, or until an earlier death, resignation, or removal. The company states there are no special arrangements or related-party transactions associated with his selection, and his compensation will follow the standard program for non-employee directors. United States Antimony later issued a press release on August 19, 2025 announcing his appointment.
United States Antimony Corporation furnished an update on its recent performance by providing access to a conference call discussing financial and operational results for the second quarter and six months ended June 30, 2025. The call was held on August 12, 2025, and a recorded replay is available on the company’s investor website until August 26, 2025.
The company is also making a written transcript of this conference call available as Exhibit 99.1, which is furnished rather than filed, meaning it is not subject to certain liability provisions of the securities laws and is not automatically incorporated into other SEC filings.
United States Antimony Corporation (UAMY) reported strong year-over-year revenue growth driven by antimony price gains: second-quarter revenue rose to $10,525,123 from $3,662,977 a year earlier and six-month revenue reached $17,525,128 versus $6,735,044. Antimony prices per pound increased sharply (quarterly average $28.32 versus $6.96), which more than offset lower sales volumes and expanded gross profit to $2,837,545 for the quarter and $5,209,275 year-to-date. The company recorded net income of $181,555 for the quarter and $728,079 for the six months.
Balance sheet and cash flow changes reflect an investment and expansion phase: total assets grew to $47,498,322 from $34,642,602, property, plant and equipment rose to $19,725,995, inventories increased to $6,812,527, and the company purchased $9,991,259 of U.S. Treasury Strips. Cash and cash equivalents declined to $5,708,660 from $18,172,120, largely from $17,384,832 used in investing activities including a $5,000,000 acquisition of Ontario mining claims (Fostung Properties) and ongoing claim acquisition commitments. The company also raised capital through stock sales and warrant exercises totaling over $7 million net proceeds year-to-date.